Here, we set out to explore the mechanistic interplay between LDHA-mediated metabolism and human AML pathophysiology by dissecting the direct cellular and molecular consequences of LDHA inhibition in AML primary patient samples and cell lines. The gene discussed is LDHA; the disease is acute myeloid leukemia.